Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Direct Acting Antivirals”

179 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 179 results

Not applicableEnded earlyNCT03483987
What this trial is testing

Re-treatment of HCV Following DAA Failure

Who this might be right for
Chronic Hepatitis C
Sanjay Gandhi Postgraduate Institute of Medical Sciences 18
Not applicableStudy completedNCT04719338
What this trial is testing

Occult HCV Infection After DAAD Treatment in Haemodialysis Patients

Who this might be right for
Hepatitis C
Alexandria University 30
Large-scale testing (Phase 3)UnknownNCT04017338
What this trial is testing

Transplantation Using Hepatitis C Positive Donors, A Safety Trial

Who this might be right for
Lung Transplant InfectionHeart Transplant InfectionKidney Transplant Infection+2 more
Jordan Feld 40
Not applicableUnknownNCT04039698
What this trial is testing

Monitoring of Hepatitis C Treatment Using Telemedicine - a Clinical Trial in Public Health System in Brazil

Who this might be right for
Chronic Hepatitis C
Hospital de Clinicas de Porto Alegre 144
Very early researchStudy completedNCT03188276
What this trial is testing

The Relationship Between MDSCs and NK Cells Activity of CHC Patient Treated by DAAs

Who this might be right for
Chronic Hepatitis C
Third Affiliated Hospital, Sun Yat-Sen University 52
Not applicableNot Yet RecruitingNCT06872047
What this trial is testing

Exploring the Knowledge, Attitudes, Behaviors and Perceived Barriers of Hepatologists Towards Non-invasive Hepatocellular Carcinoma Prediction Models in Hepatitis C Patients Who Achieved Sustained Virological Response Following Direct Acting Antivirals Therapy

Who this might be right for
Non-invasive Hepatocellular Carcinoma
Assiut University 400
Not applicableStudy completedNCT03348059
What this trial is testing

Anti-E1E2 (D32.10 Epitope-binding) Antibodies Status Prior Therapy Favors Direct-acting Antiviral Treatment Efficacy

Who this might be right for
Chronic Hepatitis c
Hospices Civils de Lyon 103
Not applicableStudy completedNCT01945008
What this trial is testing

Observational Study in HCV Chronic Infection

Who this might be right for
Hepatitis C, Chronic
Istituto Superiore di Sanità 7,600
Testing effectiveness (Phase 2)Study completedNCT02356562
What this trial is testing

Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Sofosbuvir and Ribavirin in Direct-Acting Antiviral Agent Treatment-Experienced Adults With Chronic Hepatitis C Virus Infection

Who this might be right for
Chronic Hepatitis C Infection
AbbVie 29
Not applicableUnknownNCT01944527
What this trial is testing

Use of Direct-acting Antiviral to Treat HCV Recurrence After Liver Transplantation (ANRSCO23CUPILT) Infection

Who this might be right for
HCV RecurrenceLiver TransplantationDirect-acting Antiviral Agents
ANRS, Emerging Infectious Diseases 699
Not applicableUnknownNCT05284916
What this trial is testing

Difference in Patterns of Liver Diseases Related Admissions After the Era of DAAS

Who this might be right for
Patternsof Liver Diseasesadmissions After Era of DAAS
Sohag University 200
Large-scale testing (Phase 3)Study completedNCT01604850
What this trial is testing

Sofosbuvir + Ribavirin for 12 or 16 Weeks in Treatment Experienced Subjects With Chronic Genotype 2 or 3 HCV Infection (FUSION)

Who this might be right for
Chronic Hepatitis C
Gilead Sciences 202
Testing effectiveness (Phase 2)Study completedNCT02743897
What this trial is testing

Transplanting Hepatitis C Kidneys Into Negative Kidney Recipients

Who this might be right for
End Stage Renal Disease
University of Pennsylvania 62
Post-approval studies (Phase 4)Study completedNCT03420300
What this trial is testing

EBR/GZR for HCV-1b Patients Receiving Hemodialysis

Who this might be right for
Hepatitis C
National Taiwan University Hospital 40
Testing effectiveness (Phase 2)Study completedNCT01888900
What this trial is testing

New Treatment Response in People With and Without Cirrhosis From Chronic Hepatitis C

Who this might be right for
CirrhosisChronic Hepatitis CHepatitis C+1 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 35
Not applicableStudy completedNCT06829966
What this trial is testing

Impact of Direct-acting Antiviral Drugs on The Patterns of Gut Microbiota in Patients With HCV Related Chronic Liver Diseases

Who this might be right for
Intestinal Microbiota Between Different Groups
Assiut University 30
Not applicableStudy completedNCT03342261
What this trial is testing

Benefit of DAA Therapy in HCV Monoinfected and HIV-HCV Coinfected Patients With Mixed Cryoglobulinemia

Who this might be right for
Hepatitis C, ChronicMixed Cryoglobulinemia
Hospices Civils de Lyon 47
Not applicableUnknownNCT03551002
What this trial is testing

Impact of DAA Uptake in Controlling HCV Epidemic and Modeling Interventions for HCV Elimination Among HIV-infected Persons in San Diego

Who this might be right for
Hepatitis CHepatitis C, ChronicHIV/AIDS
University of California, San Diego 450
Post-approval studies (Phase 4)UnknownNCT03296930
What this trial is testing

Effect Of DAAs For Treatment Of HCV On Normal Kidney

Who this might be right for
Antiviral Drug Adverse Reaction
Assiut University 100
Not applicableUnknownNCT02904603
What this trial is testing

Immune Monitoring of Hepatitis C Under DAA Therapy

Who this might be right for
Hepatitis C
University of Regensburg 100
Load More Results